Clinical Trial Update: Study of DCC-2812 in Participants With Advanced Genitourinary Cancers [Phase 1]

View source ↗

Summary

This clinical trial update reports that a Phase 1 study of DCC-2812 in advanced genitourinary cancers (renal cell carcinoma, urothelial carcinoma, castration-re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Renal Cell Carcinoma
• Urothelial Carcinoma

Drugs mentioned

• DCC-2812

Snippet

Sponsor: Deciphera Pharmaceuticals, LLC | Conditions: Renal Cell Carcinoma, Urothelial Carcinoma | Phase 1 | Status: RECRUITING